Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

August 25, 2016August 25, 2016

Malignant Mesothelioma Patients in Italy Seen to Enter Palliative Care Late in Disease

News

Many patients with malignant mesothelioma do not have access to palliative care prior to experiencing the worst of this aggressive cancer’s symptoms, according to a study conducted by cancer researchers in Italy. ... Read more

August 4, 2016August 4, 2016

Elderly Patients with Malignant Pleural Mesothelioma May Benefit from Surgery

News

Surgery improves overall survival in patients with malignant pleural mesothelioma, even among elderly patients, according to the results of the study, “Impact of Age on Long-Term Outcomes of Surgery for Malignant ... Read more

August 2, 2016August 2, 2016

Mesothelioma Cases Rise in Iceland Despite Asbestos Ban

News

According to recent research, mesothelioma continues to rise in Iceland, a country that was once a heavy importer of the mineral asbestos. The study “Malignant mesothelioma incidence by nationwide cancer ... Read more

July 26, 2016July 26, 2016

Positive Preclinical Results Reported in Mesothelioma Model for ONCOS-102

News

Results from a preclinical study using a mesothelioma animal model demonstrate a synergic effect of ONCOS-102, a genetically modified adenovirus, in combination with pemetrexed and cisplatin. “These findings give a strong ... Read more

July 21, 2016July 21, 2016

First Patient Recruited in Malignant Pleural Mesothelioma PhaseIb/II Trial

News

Scandinavian-based Targovax recently recruited the first patient for the Phase Ib/II study examining ONCOS-102 in combination with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma (MPM), a rare, aggressive cancer ... Read more

July 7, 2016July 7, 2016

Record Number of Mesothelioma Deaths Among Aboriginals in Western Australia Traced to Mining of Blue Asbestos

News

Indigenous people in western Australia die of mesothelioma at a higher rate than anywhere else in the world, researchers at the University of Western Australia report, with more than two-thirds of these ... Read more

June 28, 2016

Activin A May Be a Novel Mesothelioma Biomarker, Study Shows

News

In a recent study, a team of cancer specialists from Switzerland, Austria, Hungary, and Australia have found what they believe could be a new and helpful biomarker for malignant pleural ... Read more

June 16, 2016June 16, 2016

Mesothelioma Surgery Improves Patients’ Quality of Life, Findings Show

News

Although surgery can prolong the lives of patients with malignant pleural mesothelioma (MPM), many patients avoid the surgery, fearing it will degrade their quality of life. However, research led by Dr. ... Read more

June 9, 2016June 9, 2016

ASCO 2016: Updated Phase 1b Study Data on Mesothelioma Drug Presented by Five Prime Therapeutics

News

At the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Five Prime Therapeutics revealed updated results from the ongoing Phase 1b clinical trial of FP-1039 (GSK3052230) for the treatment of ... Read more

May 12, 2016May 12, 2016

Data from Phase 2 Study of Pre-surgery Treatment in MPM Patients Presented at iMig 2016

News

Dr. Raphael Bueno, chief of Thoracic Surgery at Brigham and Women’s Hospital (BWH) in Boston, recently presented clinical data of the ongoing, Verastem-sponsored Phase 2 clinical trial of a neoadjuvant treatment in people with ... Read more